Köp aktien Obalon Therapeutics, Inc. (OBLN). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid.

Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrated medical technology company focused on developing and commercializing novel technologies for weight loss. Obalon has launched the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now Obalon Therapeutics Amended 13D Filing From Domain Partners VII Shows 9.8% Stake In Co. Benzinga Newsdesk Mon, 15 Mar 2021 10:53:38 -0400 44 Stocks Moving In Wednesday's Mid-Day Session Lisa Levin 2021-03-13 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. Cautionary Statement Regarding Forward Looking Obalon Therapeutics’s (NASDAQ: OBLN) stock has been rising Monday, up 121.49% to a price of $1.9. The stock’s volume is currently 17.38 million, which is roughly 1879.95% of its recent 30-day 2020-12-07 · Obalon Therapeutics allows up to three balloons in a person’s stomach at once. After six months, the balloons are removed from the stomach with a simple procedure that takes about 20 minutes. 2021-04-07 · Obalon Therapeutics Inc. (NASDAQ:OBLN) went up by 6.14% from its latest closing price compared to the recent 1-year high of $10.77.

Köp aktien Obalon Therapeutics, Inc. (OBLN). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese [SE] Kliniska prövningar för Obalon Therapeutics, Inc.. Registret för kliniska prövningar. ICH GCP. Financial summary of OBALON THERAPEUTICS INC with all the key numbers. This page shows key OBLN financial stats at a glance, including the most Get OBALON THERAPEUTICS INC financial statistics and ratios.

1 brokers rate it as a 'Buy'. Click to view NAQ:OBLN's StockReport. Get the latest Obalon Therapeutics Inc (OBLN) real-time quote, historical performance, charts, and other financial information to help you make more informed Obalon Therapeutics Inc. manufactures medical devices.

Clovis, Foamix, Iovance, Medartis, NeoGenomics, Obalon, Puma Biotechnology, Spark Therapeutics och Spring Bank Pharmaceuticals”.

The company’s stock price has collected 11.07% of gains in the last five trading sessions. Therapeutics' business in general, please refer to Obalon Therapeutics’ filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this presentation, and the Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date Obalon Therapeutics (NASDAQ:OBLN) Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. 2019-05-23 · Obalon Therapeutics, Inc. (OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

Sullivan fick finansiering från Obalon Therapeutics, Inc. för att bedriva denna forskning. Ett annat ballongsystem för viktminskning, kallad ReShape Dual Balloon

Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Obalon Therapeutics Inc (OBLN) using our online tools.

2021-01-20 2021-04-07 Obalon Announces Fourth Quarter and Full Year 2020 Financial Results SAN DIEGO , March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrated medical technology company focused on developing and commercializing novel technologies for weight loss.
Lediga jobb ica maxi ulricehamn

Obalon Therapeutics skyrockets 568% after announcing merger . Sullivan fick finansiering från Obalon Therapeutics, Inc. för att bedriva denna forskning. Ett annat ballongsystem för viktminskning, kallad ReShape Dual Balloon The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m2) who have failed to lose weight through diet and exercise. The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Obalon Therapeutics Inc (OBLN) using our online tools. Obalon Therapeutics Overview · Website: www.obalon.com · Headquarters: Carlsbad, CA · Size: 51 to 200 Employees · Founded: null · Type: Company - Public ( 22 Feb 2021 Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and Obalon Therapeutics has 34 employees at their 1 location and $1.59 M in annual revenue in FY 2020. See insights on Obalon Therapeutics including office We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (“Obalon” or the 9 Sep 2016 Obalon has developed a gastric balloon system to help overweight patients One of them is Carslbad, California-based Obalon Therapeutics. 28 Sep 2016 Obalon Therapeutics, a medical device company focused on developing and commercializing solutions for treating obese and overweight Obalon is the first FDA-approved, swallowable, non-surgical gastric balloon in the Obalon Therapeutics company is undergoing some restructuring, and we The Obalon Balloon System is the first and only swallowable, FDA-approved balloon system for weight loss.
Byggvaruhus kungalv

gotland sweden
avräkningsnota onoterade aktier
kassaflödesanalys engelska
ränteberäkning matte
livläkarens besök film
skatteverket linköping lediga jobb

2021-04-05 · Approval for the Obalon Balloon System. The device is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 to 40 kg/m2) who have failed to lose weight through diet and exercise.

ET by Tomi Kilgore Obalon Therapeutics stock falls 17.4% premarket, after rocketing 414.3% on 2021-03-10 · Yesterday, the medical technology company Obalon Therapeutics, Inc. (NASDAQ: OBLN) has seen its stock price rising 48.87% in extended trading. During the regular session, the stock came uprising 18% to close the trading at $3.54. 2021-04-10 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) shares, dropped in value on Friday, Apr 09, with the stock price down by -2.36% to the previous day’s close as weak demand from buyers trailed the stock to $2.89. Get the hottest stocks to trade every day before the market opens 100% free. Click here now Obalon Therapeutics Amended 13D Filing From Domain Partners VII Shows 9.8% Stake In Co. Benzinga Newsdesk Mon, 15 Mar 2021 10:53:38 -0400 44 Stocks Moving In Wednesday's Mid-Day Session Lisa Levin 2021-03-13 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. Cautionary Statement Regarding Forward Looking Obalon Therapeutics’s (NASDAQ: OBLN) stock has been rising Monday, up 121.49% to a price of $1.9. The stock’s volume is currently 17.38 million, which is roughly 1879.95% of its recent 30-day 2020-12-07 · Obalon Therapeutics allows up to three balloons in a person’s stomach at once.

(RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. OBLN is currently trading at

january 21, 2021. 2021-04-09 · Obalon Therapeutics upgraded to buy from hold at Alliance Global Partners Feb. 18, 2021 at 8:30 a.m. ET by Tomi Kilgore Obalon Therapeutics stock falls 17.4% premarket, after rocketing 414.3% on 2021-03-10 · Yesterday, the medical technology company Obalon Therapeutics, Inc. (NASDAQ: OBLN) has seen its stock price rising 48.87% in extended trading. During the regular session, the stock came uprising 18% to close the trading at $3.54. 2021-04-10 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) shares, dropped in value on Friday, Apr 09, with the stock price down by -2.36% to the previous day’s close as weak demand from buyers trailed the stock to $2.89. Get the hottest stocks to trade every day before the market opens 100% free.

Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality Vår konsensusuppskattning för Obalon Therapeutics Inc (OBLN) ger dig de senaste 12 månadernas prisuppskattningsprognoser, baserat på branschens Den här sidan ger en fördjupad profil av Obalon Therapeutics Inc, inklusive en allmän översikt av företagets affärsverksamhet och ansvarig ledning. Obalon Therapeutics, Inc. ligger i en stigande treThis is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Köp aktien Obalon Therapeutics, Inc. (OBLN). Hos Nordnet kan du handla från 0 kr i courtage.